These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1420 related articles for article (PubMed ID: 25151631)

  • 1. Tailored atrial substrate modification based on low-voltage areas in catheter ablation of atrial fibrillation.
    Rolf S; Kircher S; Arya A; Eitel C; Sommer P; Richter S; Gaspar T; Bollmann A; Altmann D; Piedra C; Hindricks G; Piorkowski C
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):825-33. PubMed ID: 25151631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Box Isolation of Fibrotic Areas (BIFA): A Patient-Tailored Substrate Modification Approach for Ablation of Atrial Fibrillation.
    Kottkamp H; Berg J; Bender R; Rieger A; Schreiber D
    J Cardiovasc Electrophysiol; 2016 Jan; 27(1):22-30. PubMed ID: 26511713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Outcome of Left Atrial Voltage-Guided Substrate Ablation During Atrial Fibrillation: A Novel Adjunctive Ablation Strategy.
    Yagishita A; Gimbel JR; DE Oliveira S; Manyam H; Sparano D; Cakulev I; Mackall J; Arruda M
    J Cardiovasc Electrophysiol; 2017 Feb; 28(2):147-155. PubMed ID: 27862561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of an Adjunctive Electrophysiological Test-Guided Left Atrial Posterior Wall Isolation in Persistent Atrial Fibrillation Without a Left Atrial Low-Voltage Area.
    Yamaji H; Higashiya S; Murakami T; Hina K; Kawamura H; Murakami M; Kamikawa S; Hirohata S; Kusachi S
    Circ Arrhythm Electrophysiol; 2020 Aug; 13(8):e008191. PubMed ID: 32660260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is pursuit of termination of atrial fibrillation during catheter ablation of great value in patients with longstanding persistent atrial fibrillation?
    Park YM; Choi JI; Lim HE; Park SW; Kim YH
    J Cardiovasc Electrophysiol; 2012 Oct; 23(10):1051-8. PubMed ID: 22882600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additional Low-Voltage-Area Ablation in Patients With Paroxysmal Atrial Fibrillation: Results of the Randomized Controlled VOLCANO Trial.
    Masuda M; Asai M; Iida O; Okamoto S; Ishihara T; Nanto K; Kanda T; Tsujimura T; Matsuda Y; Okuno S; Hata Y; Mano T
    J Am Heart Assoc; 2020 Jul; 9(13):e015927. PubMed ID: 32578466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Voltage Mapping to Guide Whether to Perform Ablation of the Posterior Wall in Patients With Persistent Atrial Fibrillation.
    Cutler MJ; Johnson J; Abozguia K; Rowan S; Lewis W; Costantini O; Natale A; Ziv O
    J Cardiovasc Electrophysiol; 2016 Jan; 27(1):13-21. PubMed ID: 26515166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and electrophysiological characterization of early left atrial structural remodeling as a predictor for atrial fibrillation recurrence after pulmonary vein isolation.
    Yagishita A; Sparano D; Cakulev I; Gimbel JR; Phelan T; Mustafa H; De Oliveira S; Mackall J; Arruda M
    J Cardiovasc Electrophysiol; 2017 Jun; 28(6):642-650. PubMed ID: 28387462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catheter Ablation of Nonparoxysmal Atrial Fibrillation Using Electrophysiologically Guided Substrate Modification During Sinus Rhythm After Pulmonary Vein Isolation.
    Yang G; Yang B; Wei Y; Zhang F; Ju W; Chen H; Li M; Gu K; Lin Y; Wang B; Cao K; Kojodjojo P; Chen M
    Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003382. PubMed ID: 26857907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left atrial low-voltage areas, but not volume, predict the recurrence of atrial fibrillation in repeat ablation procedures.
    Georgi C; Bannehr M; Lochmann M; Reiners D; Haase-Fielitz A; Butter C; Seifert M
    J Cardiovasc Electrophysiol; 2024 Jun; 35(6):1156-1164. PubMed ID: 38566599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of pulmonary vein antrum isolation in patients with atrial fibrillation: an analysis in regards to substrates and pulmonary vein reconnections.
    Yamaguchi T; Tsuchiya T; Nagamoto Y; Miyamoto K; Murotani K; Okishige K; Takahashi N
    Europace; 2014 Apr; 16(4):511-20. PubMed ID: 24078342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Left Atrial Voltage-Based Catheter Ablation of Persistent Atrial Fibrillation.
    Yamaguchi T; Tsuchiya T; Nakahara S; Fukui A; Nagamoto Y; Murotani K; Eshima K; Takahashi N
    J Cardiovasc Electrophysiol; 2016 Sep; 27(9):1055-63. PubMed ID: 27235000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ablation of Persistent Atrial Fibrillation Targeting Low-Voltage Areas With Selective Activation Characteristics.
    Jadidi AS; Lehrmann H; Keyl C; Sorrel J; Markstein V; Minners J; Park CI; Denis A; Jaïs P; Hocini M; Potocnik C; Allgeier J; Hochholzer W; Herrera-Siklody C; Kim S; Omri YE; Neumann FJ; Weber R; Haïssaguerre M; Arentz T
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early pulmonary vein reconnection as a predictor of left atrial ablation outcomes for paroxysmal atrial fibrillation.
    Efremidis M; Letsas K; Giannopoulos G; Lioni L; Vlachos K; Asvestas D; Karlis D; Kareliotis V; Geladari H; Sideris A; Deftereos S
    Europace; 2015 May; 17(5):741-6. PubMed ID: 25687747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remote-controlled magnetic pulmonary vein isolation using a new three-dimensional non-fluoroscopic navigation system: a single-centre prospective study.
    Da Costa A; Ben H'dech M; Romeyer-Bouchard C; Bisch L; Gate-Martinet A; Levallois M; Isaaz K
    Arch Cardiovasc Dis; 2013; 106(8-9):423-32. PubMed ID: 23906679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new method to evaluate linear block at the left atrial roof: is it reliable without pacing?
    Sang C; Jiang C; Dong J; Liu X; Yu R; Long D; Tang R; Gao L; Ning M; Chen G; Li W; Ma C
    J Cardiovasc Electrophysiol; 2010 Jul; 21(7):741-6. PubMed ID: 20102432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective, multicenter validation of a clinical risk score for left atrial arrhythmogenic substrate based on voltage analysis: DR-FLASH score.
    Kosiuk J; Dinov B; Kornej J; Acou WJ; Schönbauer R; Fiedler L; Buchta P; Myrda K; Gąsior M; Poloński L; Kircher S; Arya A; Sommer P; Bollmann A; Hindricks G; Rolf S
    Heart Rhythm; 2015 Nov; 12(11):2207-12. PubMed ID: 26144350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of sinus rhythm as endpoint of persistent atrial fibrillation ablation.
    Ammar S; Hessling G; Reents T; Paulik M; Fichtner S; Schön P; Dillier R; Kathan S; Jilek C; Kolb C; Haller B; Deisenhofer I
    J Cardiovasc Electrophysiol; 2013 Apr; 24(4):388-95. PubMed ID: 23252615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninducibility of atrial fibrillation as an end point of left atrial circumferential ablation for paroxysmal atrial fibrillation: a randomized study.
    Oral H; Chugh A; Lemola K; Cheung P; Hall B; Good E; Han J; Tamirisa K; Bogun F; Pelosi F; Morady F
    Circulation; 2004 Nov; 110(18):2797-801. PubMed ID: 15505091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of substrate modification in catheter ablation of paroxysmal atrial fibrillation: pulmonary vein isolation alone or with complex fractionated electrogram ablation.
    Nam GB; Jin ES; Choi H; Song HG; Kim SH; Kim KH; Hwang ES; Park KM; Kim J; Rhee KS; Choi KJ; Kim YH
    Tex Heart Inst J; 2012; 39(3):372-9. PubMed ID: 22719147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 71.